Application segmentation divides the Endoscopy Video Systems market into four functional categories: Diagnostic, Therapeutic, Surgical, and Screening. Diagnostic systems are deployed primarily for visual assessment of mucosal surfaces, accounting for the largest share because they support routine examinations in gastro‑enterology, pulmonology, and urology. Therapeutic platforms integrate video output with instrument channels for interventions such as polypectomy or hemostasis, contributing a substantial portion as hospitals expand minimally invasive procedures. Surgical systems are engineered for intra‑operative visualization during complex procedures, including laparoscopy and robotic‑assisted surgery, and they drive higher average selling prices due to advanced imaging capabilities. Screening applications, focused on population‑level early‑detection programs, represent a smaller but growing niche, especially in colorectal cancer initiatives. In 2025, the diagnostic segment represented roughly 45 % of global revenue (≈ $4.5 billion), while therapeutic and surgical segments contributed about $3.0 billion and $2.0 billion respectively; the screening segment, though modest, is projected to grow at a CAGR of 8 % driven by national screening mandates. Together, these categories form the basis of the Endoscopy Video Systems segmentation, each influencing total market size through distinct adoption rates, price points, and reimbursement environments.
